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Abstract 
The human ubiquitin-conjugating enzyme UbcHl shows 69% identity to the Saccharomyces cerevisiae RAD4IUBC2 which plays a key role in DNA 
repair. To examine the function of UbcHl (formerly named E2, M, 17 000), [(1990) EMBO J. 9, 1431-14351) we tested its ability to fun~tionaliy 
substitute for yeast RAD6/UBC2 in the recovery of cells from various DNA damage. Complementation by expression of the human UbcHI cDNA 
revealed that the UbcHi carries out the function of S. cerevisiae RAD6/UBC2 in the repair of UV-damaged, alkylated and cross-linked DNA. 
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1. Introduction 
Ubiquitin is present in all eukaryotic cells and is the 
most conserved protein known so far. It is covalently 
attached to many cellular proteins and targets them to 
selective degradation. However, the presence of stable 
ubiquitin conjugates of histones H2A and H2B in chro- 
matin suggests an alternative, non-proteolytic role for 
ubiquitination, in which its reversible attachment to 
other proteins modulates their function by structural 
changes (recently reviewed in [l-3]). 
Ubiquitination of proteins requires activation of ubiq- 
uitin by an activating enzyme (El) and substrate-specific 
conjugation by ubiquitin-conjugating enzymes (E2) [4]. 
One of these E2 enzymes is the Saccharomyces cerevisiae 
RAD6/UBC2 [5]. The RAD6IUBC2 gene plays a key role 
in DNA repair, induction of mutagenesis, and sporula- 
tion. Rad6 mutants are hypersensitive to ultraviolet 
light, alkylating and cross-linking chemicals [6], are to- 
tally deficient in mutagenesis induced by these agents, 
and fail to sporulate. In cooperation with the yeast ubiq- 
uitin ligase (E3), RAD6/UBC2 ubiquitinates proteins de- 
pending on their N-terminal amino acids, subjecting 
them to protein degradation by the N-end rule pathway 
[7,8]. However, the RAD6/UBC2 protein monoubiquiti- 
nates and polyubiquitinates the histones H2A and H2B 
in vitro in an E3-independent reaction [5], and the highly 
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acidic C-terminal extension of RAD6/UBC2 is required 
for this reaction [9]. 
A remarkably conserved human homologue of RAD61 
UBC2 was originally isolated by Schneider et al. 1141, 
followed by reports of homologous enzymes in 
Schizosaccaromyces pombe [lo], Drosophila melanogaster 
[l I], Arabidopsis thaliana [12], and rabbit 1131. In human 
the existence of isoenzymes has been reported which 
share 95% identity at the amino acid level [15]. Although 
the human homologues show about 70% identity com- 
pared with RAD61UBC2, they completely lack the 
above-mentioned C-terminal acidic extension, which 
may result in functional differences. Interestingly, very 
recently we identified a human ubiquitin-conjugating en- 
zyme (UbcH2) containing a C-terminal extension en- 
riched in acidic residues which is also able to ubiquitinate 
histones [ 161. 
In addition to UbcHl’s role in repair of UV-damaged 
DNA (as shown by Koken et al. [ 15]), we were interested 
in whether it is also involved in the repair of alkylated 
and cross-linked DNA. For this purpose we expressed 
the cDNA encoding the human UbcHl in rad6 mutants 
and assayed for repair of DNA lesions induced by UV 
light, MMS (methylmethanesulfonate) and 8-MOP 
(8methoxypsoralen plus UV-A-light). 
2. Experimental 
2.1. Yeast strains and growth conditions 
The haploid S. cerevisiue strains used in this study were the RAD6+ 
strain YW02 (MATa, his3-A200, Ieu2-3, leu2-112, lys2-801, trpl- 
I (am). ~1~3-52) and the rad6A strain YW062 (MATa, his3-BOO, leu2- 
3, leu2-112. lys2-801, trpl-1 (am). ura3-52, rad6::HIS3), both kindly 
provided by W. Seufert (Universitlt M~nchen). The standard synthetic 
complete and rich media used have been described elsewhere [17]. 
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2.2. Construction of expression plasmids 
The cDNA clone UI8, encoding the human ubiquitin~onjugati~g 
enzyme UbcHl 1141, was digested with BumHI and PvuII. Klenow 
polymerase was used to fill in the BamHI site of the cDNA. After 
addition of Not1 linkers and subsequent digestion with No& the UbcHI 
insert was separated by agarose gel-electrophoresis from linker frag- 
ments and vector sequences. Cloning of the extracted UbcHf cDNA 
fragment into the unique NotI site of the 5’. cerevisiae expression vector 
YEp351-ADCI resulted in plasmid YEp351-ADCI-UbcHl, which al- 
lows the expression of the human UbcHl cDNA in S. cerevisiue. 
The expression vector YEp351-ADCI was constructed by cloning the 
BumHI fragment of plasmid YpNot [18], which contains the S. cere- 
visiue ADCI promoter and terminator separated by a Not1 site, into the 
BarnHI site of the 2p-based YEp351 [l9]. 
2.3. Cloning, sequencing and transformation 
All plasmids were propagated in the Escherichiu colt strain SURE 
(Stratagene) and isolated as described [20]. Cloning and sequencing 
methods were according to standard protocols [21]. Yeast strains were 
transformed by a modified lithium acetate protocol (221, and transfor- 
mants were analysed as described 1231. 
2.4. Survival assays with S. cerevisiae 
Yeast cells were grown in liquid synthetic complete media lacking 
leucine to mid exponential phase. To assay UV sensitivity, cells were 
plated on appropriate agar plates, incubated at 30°C for 4 h and 
irradiated with UV light at a dose rate of0.5 J-m-2.s-‘. The plates were 
incubated in the dark to avoid photoreactivation and surviving colonies 
were counted after 5-6 days. To measure the capacity to repair al- 
kylated DNA, cells were plated on MMS~ontaining plates, which were 
used immediately after preparation. Surviving colonies were counted 
after 6 days. 
To assay viability after treatment with the cross-linking agent 
8-MOP, cells were washed three times with phosphate-buffered saline 
(PBS) and incubated for 30 min at 30°C in PBS containing 5 MM 
8-MOP. The 8-MOP-treated cells were placed in a cell culture dish 
(30 x 20 mm) and exposed to various doses of UV-A light (365 nm) to 
induce DNA cross-links. Irradiated cells were washed twice with PBS 
to remove residual 8-MOP and plated on appropriate agar plates. 
Surviving colonies were counted after 6 days incubation at 3O’C. 
3. Results and discussion 
The highly homologous primary structures of the 
yeast RAD61UBC2 and the human UbcHl as well as 
compiementation experiments suggest similar cellular 
functions of these ubiquitin-conjugating enzymes [14,151. 
We were interested in if the human enzyme UbcHl has 
a central role to play in the repair of various DNA 
lesions, as proposed for RAD6KJBC2. For this purpose, 
we constructed a yeast/E. coli shuttle plasmid (YEp351- 
Not1 
\ 
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ADCI-UbcHl), which allows the constitutive expression 
of UbcHl in S. cerevisiue (Fig. 1). The expression of the 
cDNA encoding the human UbcH 1 is driven by the yeast 
ADCI promotor, and the corresponding 3’-untranslated 
sequences provide proper termination of the transcripts 
1241. To test whether the human UbcHl carries out the 
RAD6KJBC2 functions, several yeast transformants 
were made: (i) rad6d-UbcHl, a rad6 mutant expressing 
the human homologue; (ii) rad6d-351, the rad6 mutant 
transformed with plasmid 351-ADCI (expresses no 
UbcHl); (iii) RAD6’-351, a wild-type yeast carrying 
351-ADCI. In an initial experiment we compared the 
viability of these transfo~ants after UV irradiation. 
Fig. 2 shows the results of the survival assay. The human 
UbcHl significantly increases the resistance of cells to 
UV radiation. The major UV-induced DNA lesions are 
cyclobutane pyrimidine dimers and 6-4 photoproducts, 
which are preferentially repaired by a multistep repair 
process called nucleotide excision repair (NER) (recently 
reviewed in [25,26]). In contrast to photoproducts, DNA 
lesions induced by alkylating agents are repaired by a 
different pathway, namely base excision repair (BER) 
[27]. However, rad6 mutants are sensitive to alkylating 
agents [6] which indicates a connection between RAD6J 
UBC2 and BER. Involvement of the human UbcHl in 
this repair pathway was proven by complementation ex- 
periments similar to those involving UV treatment, but 
with MMS as the mutagenic agent. The viability of rad6 
mutants after such treatment was substantially increased 
by the presence of the human UbcHl (Fig. 3). At an 
MMS concentration of 0.025% survival was enhanced 
about 800-fold. Apparently, the human ubiquitin-conju- 
gating enzyme UbcHl participates in both of the differ- 
ing repair processes (NER and BER) necessary to allow 
cells to recover from UV- as well as MM&induced DNA 
damage. 
Little is known about the mechanisms involved in the 
repair of cross-linked DNA induced by photoactivated 
g-MOP, but double-strand breakage of DNA seems to 
be necessary [28]. Rad6 mutants are abnormally sensitive 
to killing by s-MOP. Therefore, we investigated if the 
complementation also extends to cross-link repair mech- 
AMP LEO 2 2p 
Fig. 1. Schematic representation of the yeast expression construct YEp351-ADCI-UbcHl. AMP, E. coli /?-lactamase gene conferring resistance to 
ampicillin; ADCI, alcohol dehydrogenase promoter from S. cerevisiae; TER, termination signals of the alcohol dehydrogenase gene from S. cerevisiue; 
UbcHl, cDNA encoding the human UbcHl; LEUZ, p-isopropylmalate dehydrogenase from S. cerevisiae conferring leucine prototrophy; 2~, 
2p element. 
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Fig. 2. Survival of yeast transformants after UV irradiation with the 
indicated dose. Results represent 3 independent experiments. Symbols 
are indicated in the legend. RAD’-35 1, wild-type; rad6d-35 1, mutant; 
rad6MJbcH 1, mutant yeast expressing human UbcHl _ 
anisms. Cross-linking of DNA was achieved by photoac- 
tivation (UV-A irradiation) of g-MOP intercalated into 
DNA. The amount of cross-links formed was controlled 
by the UV-A dose. As illustrated in Fig. 4 the presence 
of the human UbcHl substantially increased the resis- 
tance of cells to photoactivated &MOP. Compared to 
rad6 mutants, survival was enhanced about 500-fold at 
a UV-A dose of 1.5 kJ/m2. This suggests an important 
function of UbcHl in the repair of cross-linked DNA. 
In all these complementation experiments, expression 
of the human UbcHl in rad6 mutants never restored 
DNA repair processes to wild-type levels. This should 
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Fig. 3. Survival of yeast transformants treated with the indicated con- 
centrations of methyImethan~ulfonate. Results represent 3 separate 
experiments. Symbols are as in Fig. 2. 
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Fig. 4. Survival of yeast transformants treated with 8-methoxypsoralen 
and the indicated dose UV-A (365 nm). Results represent 3independent 
experiments. Symbols are as in Fig. 2. 
not be due to the different expression levels of wild-type 
RAD6 and UbcHl as it is known that expression levels 
of RAD6 can vary over a large range without affecting 
normal DNA repair processes. Neither over-expression 
of RAD6 from the strong GAL1 promoter [30] nor 
20-fold lower expression than in wild-type cells [3 l] infiu- 
ences RAD6 function with respect o DNA repair. Thus, 
the evolutionary distance between yeast and human, and 
the susceptibility of protein-protein interactions to 
amino acid substitutions, seems to hamper complete 
functional complementation. 
However, the experiments described above reveal a 
substantial role of the human ubiquitin-conjugating en- 
zyme in the recovery of cells from various DNA damage. 
Although the functions of the human UbcHl in DNA 
repair processes had been demonstrated in S. cerevisiae, 
we expected similar functions in mammalian cells. To 
verify this, UbcHl deletion mutants would be of special 
interest, however, the existence of at least two highly 
homologous UbcHl genes [I 51 might hamper gene dis- 
ruption experiments. Nevertheless, an important role of 
UbcHl in the repair of UV-damaged, alkylated and 
cross-linked DNA, as well as functions in mutagenesis 
[15], seems very likely. The question of the molecular 
basis of these UbcHl functions arises. One can speculate 
that UbcHl mediates the degradation of transcriptional 
repressors, which regulates .a set of DNA repair genes, 
by the ubiquitin-de~ndant proteolytic pathway: a func- 
tion that would be analogous to that of the proteolyti- 
tally active recA in E. coli, which induces SOS repair by 
degradation of the 1exA repressor protein [29]. Alterna- 
tively, ubiquitination of histones, which is carried out by 
UbcHl in vivo, may modulate chromatin structure and 
facilitate DNA repair processes. Experiments to investi- 
4 
gate these possible mechanisms, namely construction of 
a mutant UbcHl lacking specific histone ubiquitination 
activity and analysis of their ability to substitute the 
yeast RAD6/UBC2 functions in DNA repair, are cur- 
rently in progress. 
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